Compare $APUS vs $AZTR | Chartloom

Compare

$APUS vs $AZTR

Apimeds Pharmaceuticals US Inc · Azitra Inc

APUS

Apimeds Pharmaceuticals US Inc

AZTR

Azitra Inc

Compare $APUS vs $AZTR

Comparing Apimeds Pharmaceuticals US Inc and Azitra Inc

APUSApimeds Pharmaceuticals US Inc

AZTRAzitra Inc

APUSApimeds Pharmaceuticals US Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.8%

52W performance

-75.9%

FCF yield

-70.6%

AZTRAzitra Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-53.4%

52W performance

-82.4%

FCF yield

-531.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APUS

AZTR

Detailed metrics comparison

APUS

Apimeds Pharmaceuticals US Inc

AZTR

Azitra Inc

Market Cap

APUS$8M

AZTR$2M

Enterprise Value

APUS$22M

AZTR$-5M

Price

APUS$5.02

AZTR$0.13

P/E Ratio

APUSN/A

AZTRN/A

P/S Ratio

APUS0.00x

AZTR19.60x

EV/Sales

APUS0.00x

AZTR3.12x

EV/EBITDA

APUS0.00x

AZTR0.00x

P/B Ratio

APUS0.05x

AZTR1.09x

P/FCF Ratio

APUSN/A

AZTRN/A

EV/FCF

APUS-4.06x

AZTR0.41x

PEG Ratio

APUSN/A

AZTRN/A

Forward P/E (NTM)

APUSN/A

AZTRN/A

Forward P/S (NTM)

APUSN/A

AZTRN/A

Revenue (TTM)

APUS$0

AZTR$0

Revenue Growth (YoY)

APUSN/A

AZTRN/A

Forward Rev Growth

APUS0.0%

AZTR73.2%

Gross Margin (TTM)

APUS0.0%

AZTR0.0%

Operating Margin (TTM)

APUS0.0%

AZTR0.0%

EBITDA Margin (TTM)

APUS0.0%

AZTR0.0%

Net Margin (TTM)

APUS0.0%

AZTR0.0%

FCF Margin (TTM)

APUSN/A

AZTRN/A

Net Income (TTM)

APUS$-58M

AZTR$-5M

FCF (TTM)

APUS$-5M

AZTR$-11M

EPS (TTM)

APUS-$33.95

AZTR$0.00

ROE (TTM)

APUS-5898.0%

AZTR-28475.0%

ROA (TTM)

APUS-5261.0%

AZTR-17815.0%

ROIC (TTM)

APUS-5458.0%

AZTR-26746.0%

Cash

APUS$278K

AZTR$7M

Debt

APUS$14M

AZTR$2K

Net Cash/Debt

APUS$-14M

AZTR$7M

Current Ratio (TTM)

APUS0.51x

AZTR4.86x

Quick Ratio (TTM)

APUS0.40x

AZTR4.49x

Debt/Equity (TTM)

APUS0.14x

AZTR0.00x

Debt/Assets (TTM)

APUS0.0%

AZTR0.0%

Interest Coverage (TTM)

APUSN/A

AZTRN/A

Net Debt/EBITDA (TTM)

APUS0.00x

AZTR0.00x

Beta

APUS2.60

AZTR-1.00

52W Performance

APUS-75.9%

AZTR-82.4%

YTD Performance

APUS-69.8%

AZTR-53.4%

% from 52W High

APUS-91.6%

AZTR-88.1%

% from 52W Low

APUS232.5%

AZTR29.9%

Asset Turnover (TTM)

APUS0.00x

AZTR0.07x

FCF Yield (TTM)

APUS-70.6%

AZTR-531.3%

Earnings Yield (TTM)

APUS-767.4%

AZTR-237.7%

Dividend Yield (TTM)

APUSN/A

AZTRN/A

Rule of 40

APUS0.0

AZTR0.0

EV/GP/RG

APUSN/A

AZTRN/A

Ticker research

View APUS research View AZTR research

Metric	APUS Apimeds Pharmaceuticals US Inc	AZTR Azitra Inc
Market & Valuation
Market Cap	$8M	$2M
Enterprise Value	$22M	$-5M
Price	$5.02	$0.13
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	19.60x
EV/Sales	0.00x	3.12x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.05x	1.09x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.06x	0.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	73.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-5M
FCF (TTM)	$-5M	$-11M
EPS (TTM)	-$33.95	$0.00
ROE (TTM)	-5898.0%	-28475.0%
ROA (TTM)	-5261.0%	-17815.0%
ROIC (TTM)	-5458.0%	-26746.0%
Financial Health
Cash	$278K	$7M
Debt	$14M	$2K
Net Cash/Debt	$-14M	$7M
Current Ratio (TTM)	0.51x	4.86x
Quick Ratio (TTM)	0.40x	4.49x
Debt/Equity (TTM)	0.14x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	-1.00
52W Performance	-75.9%	-82.4%
YTD Performance	-69.8%	-53.4%
% from 52W High	-91.6%	-88.1%
% from 52W Low	232.5%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-70.6%	-531.3%
Earnings Yield (TTM)	-767.4%	-237.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APUS research	View AZTR research

Valuation

P/S Ratio

APUS

0.00x

AZTR

19.60x

EV/FCF

APUS

-4.06x

AZTR

0.41x

Growth & revenue

Forward Revenue Growth

AZTR

73.2%

APUS

0.0%

Profitability & performance

Gross Margin

APUS

0.0%

AZTR

0.0%

ROE

APUS

-5898.0%

AZTR

-28475.0%

FCF Yield %

APUS

-70.6%

AZTR

-531.3%

52-Week Performance

APUS

-75.9%

AZTR

-82.4%

Detailed metrics comparison

APUS

Apimeds Pharmaceuticals US Inc

AZTR

Azitra Inc

Market Cap

APUS$8M

AZTR$2M

Enterprise Value

APUS$22M

AZTR$-5M

Price

APUS$5.02

AZTR$0.13

P/E Ratio

APUSN/A

AZTRN/A

P/S Ratio

APUS0.00x

AZTR19.60x

EV/Sales

APUS0.00x

AZTR3.12x

EV/EBITDA

APUS0.00x

AZTR0.00x

P/B Ratio

APUS0.05x

AZTR1.09x

P/FCF Ratio

APUSN/A

AZTRN/A

EV/FCF

APUS-4.06x

AZTR0.41x

PEG Ratio

APUSN/A

AZTRN/A

Forward P/E (NTM)

APUSN/A

AZTRN/A

Forward P/S (NTM)

APUSN/A

AZTRN/A

Revenue (TTM)

APUS$0

AZTR$0

Revenue Growth (YoY)

APUSN/A

AZTRN/A

Forward Rev Growth

APUS0.0%

AZTR73.2%

Gross Margin (TTM)

APUS0.0%

AZTR0.0%

Operating Margin (TTM)

APUS0.0%

AZTR0.0%

EBITDA Margin (TTM)

APUS0.0%

AZTR0.0%

Net Margin (TTM)

APUS0.0%

AZTR0.0%

FCF Margin (TTM)

APUSN/A

AZTRN/A

Net Income (TTM)

APUS$-58M

AZTR$-5M

FCF (TTM)

APUS$-5M

AZTR$-11M

EPS (TTM)

APUS-$33.95

AZTR$0.00

ROE (TTM)

APUS-5898.0%

AZTR-28475.0%

ROA (TTM)

APUS-5261.0%

AZTR-17815.0%

ROIC (TTM)

APUS-5458.0%

AZTR-26746.0%

Cash

APUS$278K

AZTR$7M

Debt

APUS$14M

AZTR$2K

Net Cash/Debt

APUS$-14M

AZTR$7M

Current Ratio (TTM)

APUS0.51x

AZTR4.86x

Quick Ratio (TTM)

APUS0.40x

AZTR4.49x

Debt/Equity (TTM)

APUS0.14x

AZTR0.00x

Debt/Assets (TTM)

APUS0.0%

AZTR0.0%

Interest Coverage (TTM)

APUSN/A

AZTRN/A

Net Debt/EBITDA (TTM)

APUS0.00x

AZTR0.00x

Beta

APUS2.60

AZTR-1.00

52W Performance

APUS-75.9%

AZTR-82.4%

YTD Performance

APUS-69.8%

AZTR-53.4%

% from 52W High

APUS-91.6%

AZTR-88.1%

% from 52W Low

APUS232.5%

AZTR29.9%

Asset Turnover (TTM)

APUS0.00x

AZTR0.07x

FCF Yield (TTM)

APUS-70.6%

AZTR-531.3%

Earnings Yield (TTM)

APUS-767.4%

AZTR-237.7%

Dividend Yield (TTM)

APUSN/A

AZTRN/A

Rule of 40

APUS0.0

AZTR0.0

EV/GP/RG

APUSN/A

AZTRN/A

Ticker research

View APUS research View AZTR research

Metric	APUS Apimeds Pharmaceuticals US Inc	AZTR Azitra Inc
Market & Valuation
Market Cap	$8M	$2M
Enterprise Value	$22M	$-5M
Price	$5.02	$0.13
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	19.60x
EV/Sales	0.00x	3.12x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.05x	1.09x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.06x	0.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	73.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-5M
FCF (TTM)	$-5M	$-11M
EPS (TTM)	-$33.95	$0.00
ROE (TTM)	-5898.0%	-28475.0%
ROA (TTM)	-5261.0%	-17815.0%
ROIC (TTM)	-5458.0%	-26746.0%
Financial Health
Cash	$278K	$7M
Debt	$14M	$2K
Net Cash/Debt	$-14M	$7M
Current Ratio (TTM)	0.51x	4.86x
Quick Ratio (TTM)	0.40x	4.49x
Debt/Equity (TTM)	0.14x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	-1.00
52W Performance	-75.9%	-82.4%
YTD Performance	-69.8%	-53.4%
% from 52W High	-91.6%	-88.1%
% from 52W Low	232.5%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-70.6%	-531.3%
Earnings Yield (TTM)	-767.4%	-237.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APUS research	View AZTR research